Health Economics · 2004 · 943 citations · 32 references
PharmacyEconomicsCost-effectiveness AnalysisHealth EconomicsHealth Technology AssessmentCost-effectiveness ModelingCost-effectiveness ThresholdsEconomic EvaluationIncremental Cost-effectiveness AnalysisModel-based Economic EvaluationOutcome ValuationCost-effectiveness Acceptability ThresholdsCumulative Distribution Function ComparisonsCumulative Distribution Function PlotCumulative Distribution FunctionsEconomic Evaluation AppraisalHealth Outcome ValuationIncremental CostsJoint Probability Density Functions
Cost‑effectiveness acceptability curves (CEACs) are widely used to depict uncertainty in economic evaluations, yet common misconceptions arise from the textbook ogive shape, which is only one possible form and may not start at zero, reach one, or be monotonic. This paper provides a gallery of CEACs to expose these fallacies and serve as a reference guide for their proper interpretation in medical journals. © 2004 John Wiley & Sons, Ltd.
Abstract Cost‐effectiveness acceptability curves (CEACs) have been widely adopted as a method to quantify and graphically represent uncertainty in economic evaluation studies of health‐care technologies. However, there remain some common fallacies regarding the nature and shape of CEACs that largely result from the ‘textbook’ illustration of the CEAC. This ‘textbook’ CEAC shows a smooth curve starting at probability 0, with an asymptote to 1 for higher money values of the health outcome ( λ ). But this familiar ‘ogive’ shape which makes the ‘textbook’ CEAC look like a cumulative distribution function is just one special case of the CEAC. The reality is that the CEAC can take many shapes and turns because it is a graphic transformation from the cost‐effectiveness plane, where the joint density of incremental costs and effects may ‘straddle’ quadrants with attendant discontinuities and asymptotes. In fact CEACs: (i) do not have to cut the y ‐axis at 0; (ii) do not have to asymptote to 1; (iii) are not always monotonically increasing in λ ; and (iv) do not represent cumulative distribution functions (cdfs). Within this paper we present a ‘gallery’ of CEACs in order to identify the fallacies and illustrate the facts surrounding the CEAC. The aim of the paper is to serve as a reference tool to accompany the increased use of CEACs within major medical journals. Copyright © 2004 John Wiley & Sons, Ltd.
32
Costs, effects and C/E‐ratios alongside a clinical trial
Ben A. van Hout, Maiwenn Al, Gilad S. Gordon et al. · Health Economics · 1994 · 981 citations
William C. Black · Medical Decision Making · 1990 · 591 citations
Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +13